She transformed genomics. Multiomics is next: The Sequence
Cande Rogert helped solve one of sequencing's largest bottlenecks: the cost. Now she's on a quest to simplify and democratize multiomics.
Cande Rogert helped solve one of sequencing's largest bottlenecks: the cost. Now she's on a quest to simplify and democratize multiomics.
Discover how epigenomics helps scientists study gene regulation, DNA methylation, and chromatin accessibility underlying health and disease
Illumina Chief Medical Officer Eric Green visits China to explore how global collaboration will change the future of precision health
Through a year-round partnership, Illumina volunteers helped students explore STEM learning, career pathways, and new possibilities
In its fourth year, the program with San Diego Squared offers proof of what can happen when talent is paired with opportunity
| Date | Publication | Title |
|---|---|---|
| Jun 23, 2025 | Endpoints News | Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics |
| Jun 17, 2025 | Forbes | Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics |
| Jun 13, 2025 | GEN | Silver Anniversary of the Human Genome Project |
| Jun 13, 2025 | GEN | Proteomics Partnerships Move Multiomics from Theory to Practice |
| Jun 12, 2025 | Colorado State University | The pathogen hunter: Next-Generation Sequencing tracks down genetic mutations |

At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.